476 related articles for article (PubMed ID: 28870262)
1. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
[TBL] [Abstract][Full Text] [Related]
2. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
Brilhante RSN; Sales JA; da Silva MLQ; de Oliveira JS; Pereira LA; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
J Med Microbiol; 2018 Jul; 67(7):903-914. PubMed ID: 29846153
[TBL] [Abstract][Full Text] [Related]
4. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
Demirci-Duarte S; Arikan-Akdagli S; Gülmez D
Mycoses; 2021 Aug; 64(8):823-830. PubMed ID: 33934400
[TBL] [Abstract][Full Text] [Related]
5. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.
da Silva BV; Silva LB; de Oliveira DB; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
Mycopathologia; 2015 Dec; 180(5-6):333-43. PubMed ID: 26138435
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
7. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
9. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.
Pharkjaksu S; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
Med Mycol; 2018 Jun; 56(4):426-433. PubMed ID: 28992058
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.
Maria S; Barnwal G; Kumar A; Mohan K; Vinod V; Varghese A; Biswas R
Rev Iberoam Micol; 2018; 35(3):147-150. PubMed ID: 29997030
[TBL] [Abstract][Full Text] [Related]
11. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
[TBL] [Abstract][Full Text] [Related]
12. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
[TBL] [Abstract][Full Text] [Related]
14. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
[TBL] [Abstract][Full Text] [Related]
16. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
Ataides FS; Costa CR; Souza LK; Fernandes Od; Jesuino RS; Silva Mdo R
Rev Soc Bras Med Trop; 2015; 48(4):454-9. PubMed ID: 26312937
[TBL] [Abstract][Full Text] [Related]
18. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.
Ruiz LS; Khouri S; Hahn RC; da Silva EG; de Oliveira VK; Gandra RF; Paula CR
Mycopathologia; 2013 Apr; 175(3-4):231-9. PubMed ID: 23404576
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
[TBL] [Abstract][Full Text] [Related]
20. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
Branco J; Ryan AP; Pinto E Silva A; Butler G; Miranda IM; Rodrigues AG
Clin Microbiol Infect; 2022 Dec; 28(12):1655.e5-1655.e8. PubMed ID: 36028086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
